{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T04:52:14Z","timestamp":1776574334066,"version":"3.51.2"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1756-3305-7-3","type":"journal-article","created":{"date-parts":[[2014,1,2]],"date-time":"2014-01-02T08:01:19Z","timestamp":1388649679000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Cross-protective effect of a combined L5 plus L3 Leishmania major ribosomal protein based vaccine combined with a Th1 adjuvant in murine cutaneous and visceral leishmaniasis"],"prefix":"10.1186","volume":"7","author":[{"given":"Laura","family":"Ramirez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Corvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana C","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel A","family":"Ch\u00e1vez-Fumagalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diogo G","family":"Valadares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego M","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camila I","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta R","family":"Escutia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Bonay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos AP","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo AF","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Soto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,1,2]]},"reference":[{"issue":"9185","key":"1145_CR1","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/S0140-6736(98)10178-2","volume":"354","author":"BL Herwaldt","year":"1999","unstructured":"Herwaldt BL: Leishmaniasis. Lancet. 1999, 354 (9185): 1191-1199. 10.1016\/S0140-6736(98)10178-2.","journal-title":"Lancet"},{"issue":"6","key":"1145_CR2","doi-asserted-by":"publisher","first-page":"e1683","DOI":"10.1371\/journal.pntd.0001683","volume":"6","author":"J Moreno","year":"2012","unstructured":"Moreno J, Vouldoukis I, Martin V, McGahie D, Cuisinier AM, Gueguen S: Use of a LiESP\/QA-21 vaccine (CaniLeish) stimulates an appropriate Th1-dominated cell-mediated immune response in dogs. PLoS Negl Trop Dis. 2012, 6 (6): e1683-10.1371\/journal.pntd.0001683.","journal-title":"PLoS Negl Trop Dis"},{"issue":"2\u20134","key":"1145_CR3","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.vetpar.2011.04.004","volume":"181","author":"M Marcondes","year":"2011","unstructured":"Marcondes M, Ikeda FA, Vieira RF, Day MJ, Lima VM, Rossi CN, Perri SH, Biondo AW: Temporal IgG subclasses response in dogs following vaccination against Leishmania with Leishmune(R). Vet Parasitol. 2011, 181 (2\u20134): 153-159.","journal-title":"Vet Parasitol"},{"issue":"4","key":"1145_CR4","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.mib.2012.05.002","volume":"15","author":"AP Fernandes","year":"2012","unstructured":"Fernandes AP, Coelho EA, Machado-Coelho GL, Grimaldi G, Gazzinelli RT: Making an anti-amastigote vaccine for visceral leishmaniasis: rational, update and perspectives. Curr Op Microbiol. 2012, 15 (4): 476-485. 10.1016\/j.mib.2012.05.002.","journal-title":"Curr Op Microbiol"},{"issue":"2","key":"1145_CR5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.7555\/JBR.27.20120064","volume":"27","author":"JM Mutiso","year":"2013","unstructured":"Mutiso JM, Macharia JC, Kiio MN, Ichagichu JM, Rikoi H, Gicheru MM: Development of Leishmania vaccines: predicting the future from past and present experience. J Biomed Res. 2013, 27 (2): 85-102. 10.7555\/JBR.27.20120064.","journal-title":"J Biomed Res"},{"issue":"2","key":"1145_CR6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1128\/CMR.14.2.229-243.2001","volume":"14","author":"E Handman","year":"2001","unstructured":"Handman E: Leishmaniasis: current status of vaccine development. Clin Microbiol Rev. 2001, 14 (2): 229-243. 10.1128\/CMR.14.2.229-243.2001.","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"1145_CR7","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1365-3024.2008.01020.x","volume":"30","author":"L Beattie","year":"2008","unstructured":"Beattie L, Evans KJ, Kaye PM, Smith DF: Transgenic Leishmania and the immune response to infection. Parasite Immunol. 2008, 30 (4): 255-266. 10.1111\/j.1365-3024.2008.01020.x.","journal-title":"Parasite Immunol"},{"key":"1145_CR8","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/1756-3305-4-150","volume":"4","author":"J Carrion","year":"2011","unstructured":"Carrion J, Folgueira C, Soto M, Fresno M, Requena JM: Leishmania infantum HSP70-II null mutant as candidate vaccine against leishmaniasis: a preliminary evaluation. Parasit Vectors. 2011, 4: 150-10.1186\/1756-3305-4-150.","journal-title":"Parasit Vectors"},{"key":"1145_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/1756-3305-5-64","volume":"5","author":"LF Passero","year":"2012","unstructured":"Passero LF, Carvalho AK, Bordon ML, Bonfim-Melo A, Carvalho K, Kallas EG, Santos BB, Toyama MH, Paes-Leme A, Corbett CE: Proteins of Leishmania (Viannia) shawi confer protection associated with Th1 immune response and memory generation. Parasit Vectors. 2012, 5: 64-10.1186\/1756-3305-5-64.","journal-title":"Parasit Vectors"},{"issue":"10\u201311","key":"1145_CR10","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.micinf.2008.06.002","volume":"10","author":"S Iborra","year":"2008","unstructured":"Iborra S, Parody N, Abanades DR, Bonay P, Prates D, Novais FO, Barral-Netto M, Alonso C, Soto M: Vaccination with the Leishmania major ribosomal proteins plus CpG oligodeoxynucleotides induces protection against experimental cutaneous leishmaniasis in mice. Microbes Infect. 2008, 10 (10\u201311): 1133-1141.","journal-title":"Microbes Infect"},{"key":"1145_CR11","first-page":"ID 173039","volume":"2009","author":"M Soto","year":"2009","unstructured":"Soto M, Ramirez L, Pineda MA, Gonzalez VM, Entringer PF, de Oliveira Indiani C, Nascimento IP, Souza AP, Corvo L, Alonso C: Searching genes encoding Leishmania antigens for diagnosis and protection. Scholar Res Exch. 2009, 2009: ID 173039-","journal-title":"Scholar Res Exch"},{"issue":"3","key":"1145_CR12","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.trsl.2013.03.006","volume":"162","author":"CM Beaumier","year":"2013","unstructured":"Beaumier CM, Gillespie PM, Hotez PJ, Bottazzi ME: New vaccines for neglected parasitic diseases and dengue. Transl Res. 2013, 162 (3): 144-155. 10.1016\/j.trsl.2013.03.006.","journal-title":"Transl Res"},{"issue":"2","key":"1145_CR13","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.vaccine.2011.11.005","volume":"30","author":"MS Duthie","year":"2012","unstructured":"Duthie MS, Raman VS, Piazza FM, Reed SG: The development and clinical evaluation of second-generation leishmaniasis vaccines. Vaccine. 2012, 30 (2): 134-141. 10.1016\/j.vaccine.2011.11.005.","journal-title":"Vaccine"},{"issue":"5","key":"1145_CR14","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/S0169-4758(00)01637-9","volume":"16","author":"IL Mauricio","year":"2000","unstructured":"Mauricio IL, Stothard JR, Miles MA: The strange case of Leishmania chagasi. Parasitol Today. 2000, 16 (5): 188-189. 10.1016\/S0169-4758(00)01637-9.","journal-title":"Parasitol Today"},{"issue":"12\u201313","key":"1145_CR15","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.micinf.2010.06.008","volume":"12","author":"MA Chavez-Fumagalli","year":"2010","unstructured":"Chavez-Fumagalli MA, Costa MA, Oliveira DM, Ramirez L, Costa LE, Duarte MC, Martins VT, Oliveira JS, Olortegi CC, Bonay P: Vaccination with the Leishmania infantum ribosomal proteins induces protection in BALB\/c mice against Leishmania chagasi and Leishmania amazonensis challenge. Microbes Infect. 2010, 12 (12\u201313): 967-977.","journal-title":"Microbes Infect"},{"issue":"9","key":"1145_CR16","doi-asserted-by":"publisher","first-page":"5842","DOI":"10.1128\/IAI.73.9.5842-5852.2005","volume":"73","author":"S Iborra","year":"2005","unstructured":"Iborra S, Carrion J, Anderson C, Alonso C, Sacks D, Soto M: Vaccination with the Leishmania infantum acidic ribosomal P0 protein plus CpG oligodeoxynucleotides induces protection against cutaneous leishmaniasis in C57BL\/6 mice but does not prevent progressive disease in BALB\/c mice. Infect Immun. 2005, 73 (9): 5842-5852. 10.1128\/IAI.73.9.5842-5852.2005.","journal-title":"Infect Immun"},{"key":"1145_CR17","doi-asserted-by":"publisher","first-page":"181690","DOI":"10.1155\/2010\/181690","volume":"2010","author":"L Ramirez","year":"2010","unstructured":"Ramirez L, Iborra S, Cortes J, Bonay P, Alonso C, Barral-Netto M, Soto M: BALB\/c mice vaccinated with Leishmania major ribosomal proteins extracts combined with CpG oligodeoxynucleotides become resistant to disease caused by a secondary parasite challenge. J Biomed Biotechnol. 2010, 2010: 181690-","journal-title":"J Biomed Biotechnol"},{"issue":"9","key":"1145_CR18","doi-asserted-by":"publisher","first-page":"5827","DOI":"10.1128\/IAI.73.9.5827-5834.2005","volume":"73","author":"TR de Moura","year":"2005","unstructured":"de Moura TR, Novais FO, Oliveira F, Clarencio J, Noronha A, Barral A, Brodskyn C, de Oliveira CI: Toward a novel experimental model of infection to study American cutaneous leishmaniasis caused by Leishmania braziliensis. Infect Immun. 2005, 73 (9): 5827-5834. 10.1128\/IAI.73.9.5827-5834.2005.","journal-title":"Infect Immun"},{"issue":"9","key":"1145_CR19","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.vaccine.2012.12.071","volume":"31","author":"L Ramirez","year":"2013","unstructured":"Ramirez L, Santos DM, Souza AP, Coelho EA, Barral A, Alonso C, Escutia MR, Bonay P, de Oliveira CI, Soto M: Evaluation of immune responses and analysis of the effect of vaccination of the Leishmania major recombinant ribosomal proteins L3 or L5 in two different murine models of cutaneous leishmaniasis. Vaccine. 2013, 31 (9): 1312-1319. 10.1016\/j.vaccine.2012.12.071.","journal-title":"Vaccine"},{"issue":"7","key":"1145_CR20","doi-asserted-by":"publisher","first-page":"3988","DOI":"10.1128\/IAI.71.7.3988-3994.2003","volume":"71","author":"EA Coelho","year":"2003","unstructured":"Coelho EA, Tavares CA, Carvalho FA, Chaves KF, Teixeira KN, Rodrigues RC, Charest H, Matlashewski G, Gazzinelli RT, Fernandes AP: Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection. Infect Immun. 2003, 71 (7): 3988-3994. 10.1128\/IAI.71.7.3988-3994.2003.","journal-title":"Infect Immun"},{"issue":"6","key":"1145_CR21","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.2144\/97236bm15","volume":"23","author":"PY Shi","year":"1997","unstructured":"Shi PY, Maizels N, Weiner AM: Recovery of soluble, active recombinant protein from inclusion bodies. Biotechniques. 1997, 23 (6): 1036-1038.","journal-title":"Biotechniques"},{"issue":"12","key":"1145_CR22","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1084\/jem.20020147","volume":"195","author":"EG Rhee","year":"2002","unstructured":"Rhee EG, Mendez S, Shah JA, Wu CY, Kirman JR, Turon TN, Davey DF, Davis H, Klinman DM, Coler RN: Vaccination with heat-killed Leishmania antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long-term memory CD4+ and CD8+ T cell responses and protection against Leishmania major infection. J Exp Med. 2002, 195 (12): 1565-1573. 10.1084\/jem.20020147.","journal-title":"J Exp Med"},{"issue":"9","key":"1145_CR23","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1128\/AAC.39.9.2167","volume":"39","author":"PA Buffet","year":"1995","unstructured":"Buffet PA, Sulahian A, Garin YJ, Nassar N, Derouin F: Culture microtitration: a sensitive method for quantifying Leishmania infantum in tissues of infected mice. Antimicrob Agents Chemothe. 1995, 39 (9): 2167-2168. 10.1128\/AAC.39.9.2167.","journal-title":"Antimicrob Agents Chemothe"},{"issue":"9","key":"1145_CR24","doi-asserted-by":"publisher","first-page":"4648","DOI":"10.1128\/IAI.00394-07","volume":"75","author":"RN Coler","year":"2007","unstructured":"Coler RN, Goto Y, Bogatzki L, Raman V, Reed SG: Leish-111f, a recombinant polyprotein vaccine that protects against visceral leishmaniasis by elicitation of CD4+ T cells. Infect Immun. 2007, 75 (9): 4648-4654. 10.1128\/IAI.00394-07.","journal-title":"Infect Immun"},{"issue":"50","key":"1145_CR25","doi-asserted-by":"publisher","first-page":"7036","DOI":"10.1016\/j.vaccine.2009.09.066","volume":"27","author":"S Bertholet","year":"2009","unstructured":"Bertholet S, Goto Y, Carter L, Bhatia A, Howard RF, Carter D, Coler RN, Vedvick TS, Reed SG: Optimized subunit vaccine protects against experimental leishmaniasis. Vaccine. 2009, 27 (50): 7036-7045. 10.1016\/j.vaccine.2009.09.066.","journal-title":"Vaccine"},{"issue":"7","key":"1145_CR26","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nri1396","volume":"4","author":"RJ Ulevitch","year":"2004","unstructured":"Ulevitch RJ: Therapeutics targeting the innate immune system. Nat Rev Immunol. 2004, 4 (7): 512-520. 10.1038\/nri1396.","journal-title":"Nat Rev Immunol"},{"key":"1145_CR27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1749-6632.1993.tb22865.x","volume":"681","author":"RL Coffman","year":"1993","unstructured":"Coffman RL: Mechanisms of helper T-cell regulation of B-cell activity. Ann N Y Acad Sci. 1993, 681: 25-28. 10.1111\/j.1749-6632.1993.tb22865.x.","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"1145_CR28","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/S0169-4758(00)01651-3","volume":"16","author":"JM Requena","year":"2000","unstructured":"Requena JM, Alonso C, Soto M: Evolutionarily conserved proteins as prominent immunogens during Leishmania infections. Parasitol Today. 2000, 16 (6): 246-250. 10.1016\/S0169-4758(00)01651-3.","journal-title":"Parasitol Today"},{"issue":"7","key":"1145_CR29","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/j.vaccine.2009.11.075","volume":"28","author":"A Meddeb-Garnaoui","year":"2010","unstructured":"Meddeb-Garnaoui A, Toumi A, Ghelis H, Mahjoub M, Louzir H, Chenik M: Cellular and humoral responses induced by Leishmania histone H2B and its divergent and conserved parts in cutaneous and visceral leishmaniasis patients, respectively. Vaccine. 2010, 28 (7): 1881-1886. 10.1016\/j.vaccine.2009.11.075.","journal-title":"Vaccine"},{"issue":"1","key":"1145_CR30","doi-asserted-by":"publisher","first-page":"498","DOI":"10.4049\/jimmunol.166.1.498","volume":"166","author":"P Probst","year":"2001","unstructured":"Probst P, Stromberg E, Ghalib HW, Mozel M, Badaro R, Reed SG, Webb JR: Identification and characterization of T cell-stimulating antigens from Leishmania by CD4 T cell expression cloning. J Immunol. 2001, 166 (1): 498-505.","journal-title":"J Immunol"},{"key":"1145_CR31","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3389\/fimmu.2012.00058","volume":"3","author":"L Soong","year":"2012","unstructured":"Soong L: Subversion and Utilization of Host Innate Defense by Leishmania amazonensis. Front Immunol. 2012, 3: 58-","journal-title":"Front Immunol"},{"issue":"4","key":"1145_CR32","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.vetpar.2008.09.015","volume":"158","author":"BA Pereira","year":"2008","unstructured":"Pereira BA, Alves CR: Immunological characteristics of experimental murine infection with Leishmania (Leishmania) amazonensis. Vet Parasitol. 2008, 158 (4): 239-255. 10.1016\/j.vetpar.2008.09.015.","journal-title":"Vet Parasitol"},{"issue":"3","key":"1145_CR33","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/j.1365-2249.2004.02702.x","volume":"139","author":"S Farajnia","year":"2005","unstructured":"Farajnia S, Mahboudi F, Ajdari S, Reiner NE, Kariminia A, Alimohammadian MH: Mononuclear cells from patients recovered from cutaneous leishmaniasis respond to Leishmania major amastigote class I nuclease with a predominant Th1-like response. Clin Exp Immunol. 2005, 139 (3): 498-505. 10.1111\/j.1365-2249.2004.02702.x.","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"1145_CR34","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1128\/iai.63.9.3559-3566.1995","volume":"63","author":"L Soong","year":"1995","unstructured":"Soong L, Duboise SM, Kima P, McMahon-Pratt D: Leishmania pifanoi amastigote antigens protect mice against cutaneous leishmaniasis. Infect Immun. 1995, 63 (9): 3559-3566.","journal-title":"Infect Immun"},{"issue":"11","key":"1145_CR35","doi-asserted-by":"publisher","first-page":"6270","DOI":"10.1128\/IAI.71.11.6270-6278.2003","volume":"71","author":"K Campbell","year":"2003","unstructured":"Campbell K, Diao H, Ji J, Soong L: DNA immunization with the gene encoding P4 nuclease of Leishmania amazonensis protects mice against cutaneous leishmaniasis. Infect Immun. 2003, 71 (11): 6270-6278. 10.1128\/IAI.71.11.6270-6278.2003.","journal-title":"Infect Immun"},{"key":"1145_CR36","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1146\/annurev.immunol.16.1.495","volume":"16","author":"MK Gately","year":"1998","unstructured":"Gately MK, Renzetti LM, Magram J, Stern AS, Adorini L, Gubler U, Presky DH: The interleukin-12\/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu Rev Immunol. 1998, 16: 495-521. 10.1146\/annurev.immunol.16.1.495.","journal-title":"Annu Rev Immunol"},{"issue":"27\u201328","key":"1145_CR37","doi-asserted-by":"publisher","first-page":"5645","DOI":"10.1016\/j.vaccine.2006.03.023","volume":"24","author":"M Calvopina","year":"2006","unstructured":"Calvopina M, Barroso PA, Marco JD, Korenaga M, Cooper PJ, Nonaka S, Hashiguchi Y: Efficacy of vaccination with a combination of Leishmania amastigote antigens and the lipid A-analogue ONO-4007 for immunoprophylaxis and immunotherapy against Leishmania amazonensis infection in a murine model of New World cutaneous leishmaniasis. Vaccine. 2006, 24 (27\u201328): 5645-5652.","journal-title":"Vaccine"},{"issue":"25\u201326","key":"1145_CR38","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.1016\/S0264-410X(03)00427-4","volume":"21","author":"EF Pinto","year":"2003","unstructured":"Pinto EF, de Mello CM, Rossi-Bergmann B: Interferon-gamma-inducing oral vaccination with Leishmania amazonensis antigens protects BALB\/c and C57BL\/6 mice against cutaneous leishmaniasis. Vaccine. 2003, 21 (25\u201326): 3534-3541.","journal-title":"Vaccine"},{"issue":"8","key":"1145_CR39","doi-asserted-by":"publisher","first-page":"4521","DOI":"10.1128\/IAI.72.8.4521-4527.2004","volume":"72","author":"EF Pinto","year":"2004","unstructured":"Pinto EF, Pinheiro RO, Rayol A, Larraga V, Rossi-Bergmann B: Intranasal vaccination against cutaneous leishmaniasis with a particulated leishmanial antigen or DNA encoding LACK. Infect Immun. 2004, 72 (8): 4521-4527. 10.1128\/IAI.72.8.4521-4527.2004.","journal-title":"Infect Immun"},{"issue":"1","key":"1145_CR40","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.imlet.2005.12.002","volume":"105","author":"MX Hernandez","year":"2006","unstructured":"Hernandez MX, Barcante TA, Vilela L, Tafuri WL, Afonso LC, Vieira LQ: Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12\/23p40. Immunol Lett. 2006, 105 (1): 38-47. 10.1016\/j.imlet.2005.12.002.","journal-title":"Immunol Lett"},{"issue":"9","key":"1145_CR41","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.micinf.2007.05.012","volume":"9","author":"FH Zanin","year":"2007","unstructured":"Zanin FH, Coelho EA, Tavares CA, Marques-da-Silva EA, Silva Costa MM, Rezende SA, Gazzinelli RT, Fernandes AP: Evaluation of immune responses and protection induced by A2 and nucleoside hydrolase (NH) DNA vaccines against Leishmania chagasi and Leishmania amazonensis experimental infections. Microbes Infect. 2007, 9 (9): 1070-1077. 10.1016\/j.micinf.2007.05.012.","journal-title":"Microbes Infect"},{"issue":"33","key":"1145_CR42","doi-asserted-by":"publisher","first-page":"5491","DOI":"10.1016\/j.vaccine.2010.04.109","volume":"28","author":"HL de Matos Guedes","year":"2010","unstructured":"de Matos Guedes HL, Pinheiro RO, Chaves SP, De-Simone SG, Rossi-Bergmann B: Serine proteases of Leishmania amazonensis as immunomodulatory and disease-aggravating components of the crude LaAg vaccine. Vaccine. 2010, 28 (33): 5491-5496. 10.1016\/j.vaccine.2010.04.109.","journal-title":"Vaccine"},{"issue":"11","key":"1145_CR43","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.4161\/hv.7.11.17752","volume":"7","author":"L Kedzierski","year":"2011","unstructured":"Kedzierski L: Leishmaniasis. Hum Vaccin. 2011, 7 (11): 1204-1214. 10.4161\/hv.7.11.17752.","journal-title":"Hum Vaccin"},{"issue":"1","key":"1145_CR44","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1128\/IAI.71.1.401-410.2003","volume":"71","author":"S Ahmed","year":"2003","unstructured":"Ahmed S, Colmenares M, Soong L, Goldsmith-Pestana K, Munstermann L, Molina R, McMahon-Pratt D: Intradermal infection model for pathogenesis and vaccine studies of murine visceral leishmaniasis. Infect Immun. 2003, 71 (1): 401-410. 10.1128\/IAI.71.1.401-410.2003.","journal-title":"Infect Immun"},{"issue":"3","key":"1145_CR45","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1007\/s00436-011-2628-5","volume":"110","author":"DM Oliveira","year":"2012","unstructured":"Oliveira DM, Costa MA, Chavez-Fumagalli MA, Valadares DG, Duarte MC, Costa LE, Martins VT, Gomes RF, Melo MN, Soto M: Evaluation of parasitological and immunological parameters of Leishmania chagasi infection in BALB\/c mice using different doses and routes of inoculation of parasites. Parasitol Res. 2012, 110 (3): 1277-1285. 10.1007\/s00436-011-2628-5.","journal-title":"Parasitol Res"},{"issue":"6","key":"1145_CR46","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1590\/S0074-02762010000600015","volume":"105","author":"RF Grenfell","year":"2010","unstructured":"Grenfell RF, Marques-da-Silva EA, Souza-Testasicca MC, Coelho EA, Fernandes AP, Afonso LC, Rezende SA: Antigenic extracts of Leishmania braziliensis and Leishmania amazonensis associated with saponin partially protects BALB\/c mice against Leishmania chagasi infection by suppressing IL-10 and IL-4 production. Mem Inst Oswaldo Cruz. 2010, 105 (6): 818-822. 10.1590\/S0074-02762010000600015.","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"3","key":"1145_CR47","doi-asserted-by":"publisher","first-page":"e2148","DOI":"10.1371\/journal.pntd.0002148","volume":"7","author":"VT Martins","year":"2013","unstructured":"Martins VT, Chavez-Fumagalli MA, Costa LE, Canavaci AM, Lage PS, Lage DP, Duarte MC, Valadares DG, Magalhaes RD, Ribeiro TG: Antigenicity and protective efficacy of a Leishmania amastigote-specific protein, member of the super-oxygenase family, against visceral leishmaniasis. PLoS Negl Trop Dis. 2013, 7 (3): e2148-10.1371\/journal.pntd.0002148.","journal-title":"PLoS Negl Trop Dis"},{"key":"1145_CR48","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.0105-2896.2004.00188.x","volume":"201","author":"PM Kaye","year":"2004","unstructured":"Kaye PM, Svensson M, Ato M, Maroof A, Polley R, Stager S, Zubairi S, Engwerda CR: The immunopathology of experimental visceral leishmaniasis. Immunol Rev. 2004, 201: 239-253. 10.1111\/j.0105-2896.2004.00188.x.","journal-title":"Immunol Rev"},{"issue":"4","key":"1145_CR49","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1007\/s00436-012-3028-1","volume":"111","author":"DG Valadares","year":"2012","unstructured":"Valadares DG, Duarte MC, Ramirez L, Chavez-Fumagalli MA, Lage PS, Martins VT, Costa LE, Ribeiro TG, Regis WC, Soto M: Therapeutic efficacy induced by the oral administration of Agaricus blazei Murill against Leishmania amazonensis. Parasitol Research. 2012, 111 (4): 1807-1816. 10.1007\/s00436-012-3028-1.","journal-title":"Parasitol Research"},{"issue":"11","key":"1145_CR50","doi-asserted-by":"crossref","first-page":"5374","DOI":"10.4049\/jimmunol.158.11.5374","volume":"158","author":"L Soong","year":"1997","unstructured":"Soong L, Chang CH, Sun J, Longley BJ, Ruddle NH, Flavell RA, McMahon-Pratt D: Role of CD4+ T cells in pathogenesis associated with Leishmania amazonensis infection. J Immunol. 1997, 158 (11): 5374-5383.","journal-title":"J Immunol"},{"issue":"4","key":"1145_CR51","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.micpath.2004.11.002","volume":"38","author":"ME Wilson","year":"2005","unstructured":"Wilson ME, Jeronimo SM, Pearson RD: Immunopathogenesis of infection with the visceralizing Leishmania species. Microb Pathog. 2005, 38 (4): 147-160. 10.1016\/j.micpath.2004.11.002.","journal-title":"Microb Pathog"},{"issue":"5","key":"1145_CR52","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.4049\/jimmunol.179.5.3161","volume":"179","author":"R Silvestre","year":"2007","unstructured":"Silvestre R, Cordeiro-Da-Silva A, Santarem N, Vergnes B, Sereno D, Ouaissi A: SIR2-Deficient Leishmania infantum induces a defined IFN-gamma\/IL-10 pattern that correlates with protection. J Immunol. 2007, 179 (5): 3161-3170.","journal-title":"J Immunol"},{"issue":"35","key":"1145_CR53","doi-asserted-by":"publisher","first-page":"4585","DOI":"10.1016\/j.vaccine.2008.05.091","volume":"26","author":"DM Resende","year":"2008","unstructured":"Resende DM, Caetano BC, Dutra MS, Penido ML, Abrantes CF, Verly RM, Resende JM, Pilo-Veloso D, Rezende SA, Bruna-Romero O: Epitope mapping and protective immunity elicited by adenovirus expressing the Leishmania amastigote specific A2 antigen: correlation with IFN-gamma and cytolytic activity by CD8+ T cells. Vaccine. 2008, 26 (35): 4585-4593. 10.1016\/j.vaccine.2008.05.091.","journal-title":"Vaccine"},{"issue":"6","key":"1145_CR54","first-page":"238","volume":"119","author":"A Awasthi","year":"2004","unstructured":"Awasthi A, Mathur RK, Saha B: Immune response to Leishmania infection. Indian J Med Res. 2004, 119 (6): 238-258.","journal-title":"Indian J Med Res"},{"issue":"10","key":"1145_CR55","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1002\/1521-4141(2001010)31:10<2848::AID-IMMU2848>3.0.CO;2-T","volume":"31","author":"ML Murphy","year":"2001","unstructured":"Murphy ML, Wille U, Villegas EN, Hunter CA, Farrell JP: IL-10 mediates susceptibility to Leishmania donovani infection. Eur J Immunol. 2001, 31 (10): 2848-2856. 10.1002\/1521-4141(2001010)31:10<2848::AID-IMMU2848>3.0.CO;2-T.","journal-title":"Eur J Immunol"},{"issue":"11","key":"1145_CR56","doi-asserted-by":"publisher","first-page":"6284","DOI":"10.1128\/IAI.70.11.6284-6293.2002","volume":"70","author":"HW Murray","year":"2002","unstructured":"Murray HW, Lu CM, Mauze S, Freeman S, Moreira AL, Kaplan G, Coffman RL: Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy. Infect Immun. 2002, 70 (11): 6284-6293. 10.1128\/IAI.70.11.6284-6293.2002.","journal-title":"Infect Immun"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-3305-7-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T11:34:06Z","timestamp":1688902446000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/1756-3305-7-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,2]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["1145"],"URL":"https:\/\/doi.org\/10.1186\/1756-3305-7-3","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,2]]},"assertion":[{"value":"24 September 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"3"}}